REG - Indivior PLC - Transaction in Own Shares

IndiviorAnnouncement

15/10/2024 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241015:nRSO1347Ia&default-theme=true

RNS Number : 1347I  Indivior PLC  15 October 2024

INDIVIOR PLC

SHARE REPURCHASE PROGRAM

WEEKLY REPORT

October 15, 2024

INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total
of 634,706 of its ordinary shares of $0.50 each through Morgan Stanley &
Co. International Plc in the period from October 7, 2024, up to and including
October 11, 2024, in connection with its $100m Share Repurchase Program.
Aggregated information on the purchase of these shares can be found in the
table below.

Following the purchase and cancellation of the above shares (including those
purchased but not yet settled), Indivior has 128,588,498 ordinary shares of
$0.50 each with voting rights in issue. There are no shares held in treasury.

The above figure (128,588,498) may be used by shareholders (and others with
notification obligations) as the denominator for the calculation by which they
will determine if they are required to notify their interest in, or a change
to their interest in, Indivior under the FCA's Disclosure Guidance and
Transparency Rules.

All repurchases by Indivior are "On Exchange" transactions (as such term is
defined in the rules of the London Stock Exchange) and "on market" for the
purposes of the Companies Act 2006.

Aggregated information

 Trading Date  Trading Venue  Aggregated daily volume (number of shares)  Daily weighted average purchase price of the shares (p)
 07/10/2024    LSE            44,156                                      781.57
 07/10/2024    BATE           14,086                                      780.37
 07/10/2024    CHIX           30,066                                      780.27
 07/10/2024    AQUIS          1,192                                       782.00
 08/10/2024    LSE            41,482                                      762.27
 08/10/2024    BATE           12,057                                      760.92
 08/10/2024    CHIX           32,033                                      760.56
 08/10/2024    AQUIS          4,094                                       759.62
 09/10/2024    LSE            74,907                                      748.21
 09/10/2024    BATE           28,779                                      749.47
 09/10/2024    CHIX           30,411                                      750.91
 09/10/2024    AQUIS          6,907                                       749.58
 10/10/2024    LSE            80,169                                      632.61
 10/10/2024    BATE           24,987                                      620.76
 10/10/2024    CHIX           29,698                                      659.19
 10/10/2024    AQUIS          7,544                                       642.58
 11/10/2024    LSE            93,906                                      580.88
 11/10/2024    BATE           28,198                                      581.47
 11/10/2024    CHIX           39,841                                      578.72
 11/10/2024    AQUIS          10,193                                      580.01

 

Transaction details

In accordance with Article 5(1)(b) of the assimilated Market Abuse Regulation
(EU) No 596/2014, as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018 and Commission Delegated Regulation (EU)
2016/1052, a full breakdown of the individual purchases of ordinary shares
made by Morgan Stanley & Co. International Plc on behalf of Indivior
during the above period as part of the Share Repurchase Program can be found
at
www.indivior.com/en/investors/shareholder-information/share-repurchase-program
(http://www.indivior.com/en/investors/shareholder-information/share-repurchase-program)
.

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSGZMMGNDDGDZM